The Mays Cancer Center is an Organized Research Unit of UT Health San Antonio. As a National Cancer Institute-designated Cancer Center, Mays Cancer Center has a formal membership policy in support of the center\u2019s mission to promote interdisciplinary research in cancer-related areas of basic science, clinical research and cancer prevention and control, and to foster the application of the results of that research in the community setting, especially in the South Texas community served by the center. Mays Cancer Center members include those who serve as a principal investigator on a National Institutes of Health research project grant or other equivalent peer-reviewed, cancer-related grant or who are a principal or co-investigator of cancer center clinical trials.<\/p>\n
Mays Cancer Center welcomes the following new members from Fiscal Year 2022.<\/p>\n
<\/p>\n
Carissia Calvo-Strube, MD<\/strong>, Assistant Professor, Division of Surgical Oncology, Breast Oncology<\/p>\n Research interests<\/em>: surgical interventions in breast cancer<\/p>\n <\/p>\n Marcela Mazo Canola, MD<\/strong>, Assistant Professor, Department of Medicine, Division of Hematology\/Medical Oncology, Breast Oncology<\/p>\n Research interests<\/em>: development of new therapeutics in breast cancer<\/p>\n <\/p>\n Vaida Glatt, PhD<\/strong>, Assistant Professor, Department of Orthopaedic Surgery<\/p>\n Research interests<\/em>: development of novel therapeutics\u00a0for the treatment of bone cancers<\/p>\n <\/p>\n Rueben Harris, PhD<\/strong>, Chair, Department of Biochemistry and Structural Biology<\/p>\n Research interests<\/em>: contribution of apolipoprotein B mRNA editing enzyme, catalytic polypeptides (APOBEC) to cancer progression and tumor evolution, from the initial stages of transformation to the later stages of metastasis and therapy resistance<\/p>\n <\/p>\n Gang Huang, PhD<\/strong>, Professor, Department of Cell Systems and Anatomy<\/p>\n Research interests<\/em>: genetic and epigenetic regulators and signaling pathways involved in hematological malignancies<\/p>\n <\/p>\n Lingtao Jin, PhD<\/strong>, Associate Professor, Department of Molecular Medicine<\/p>\n Research interests<\/em>: understanding the signaling basis of cancer metabolism, with focus on the function of metabolic enzymes and onco-metabolites in cancer and therapy resistance<\/p>\n <\/p>\n Supreet Kaur, MD<\/strong>, Assistant Professor, Department of Medicine, Division of Hematology\/Medical Oncology, Lymphoma\/Thoracic Oncology<\/p>\n Research interests<\/em>: development of new therapeutics for lymphoma and thoracic cancers<\/p>\n <\/p>\n William Kelly, MD<\/strong>, Assistant Professor, Department of Medicine,\u00a0Division of Hematology\/Medical Oncology, Neuro-oncology\u00a0and Thoracic Oncology<\/p>\n Research interests<\/em>: development of new therapeutics in brain and thoracic cancers<\/p>\n <\/p>\n Debra Kent, DNP<\/strong>, Director, Survivorship Care<\/p>\n Research interests<\/em>: survivorship resources for patients with cancer<\/p>\n <\/p>\n Alexander V. Mazin, PhD<\/strong>, Professor, Department of Biochemistry and Structural Biology<\/p>\n Research interests<\/em>: the role of DNA repair\u00a0in cancer development and progression<\/p>\n <\/p>\n Devi Meyyappan, MD<\/strong>, Assistant Professor, Department of Medicine,\u00a0Division of Hematology\/Medical Oncology,\u00a0Head and Neck Cancers<\/p>\n Research interests<\/em>: development of new therapeutics in head and neck cancers<\/p>\n <\/p>\n Neil Newman, MD, MS<\/strong>, Assistant Professor, Department of Radiation Oncology,\u00a0Gastrointestinal Oncology<\/p>\n Research interests<\/em>: development of new radiation oncology\u00a0treatments for gastrointestinal cancers<\/p>\n <\/p>\n Zohra Nooruddin, MD<\/strong>, Associate Professor, Department of Medicine, Division of Hematology\/Medical Oncology, Hematology\/Oncology\u00a0and Palliative Medicine<\/p>\n Research interests<\/em>: development of new therapeutics in hematological malignancies<\/p>\n <\/p>\n Shruti Pandita, MD<\/strong>, Assistant Professor, Department of Medicine, Division of Hematology\/Medical Oncology, Gastrointestinal Oncology<\/p>\n Research interests<\/em>: development of new therapeutics for gastrointestinal cancers<\/p>\n <\/p>\n Lixin Song, PhD<\/strong>, Professor, School of Nursing<\/p>\n Research interests<\/em>: smart design to enhance survivorship care\u00a0and health outcomes for patients with cancer and their family\u00a0caregivers during post-treatment care transitions<\/p>\n <\/p>\n Xiaoli Sun, MD, PhD<\/strong>, Assistant Professor, Department of Pharmacology<\/p>\n Research interests<\/em>: understanding the pathophysiology and identifying novel therapeutic targets for liver cancer<\/p>\n <\/p>\n Elizabeth Wasmuth, PhD<\/strong>, Assistant Professor, Department of Biochemistry and Structural Biology<\/p>\n Research interests<\/em>: therapeutic targets in prostate cancer<\/p>\n <\/p>\n Murali Yallapu, PhD<\/strong>, Assistant Professor, Department of Immunology and Microbiology<\/p>\n Research interests<\/em>: development of nanomedicine\u00a0for cancer progression<\/p>\n <\/p>\n Mansour Zadeh, PhD<\/strong>, Distinguished Professor, Department of Medicine,\u00a0Division of Gastroenterology<\/p>\n Research interests<\/em>: microbiome and mucosal biology\u00a0in cancer<\/p>\n <\/p>\n Peng Zhao, PhD<\/strong>, Assistant Professor, Department of Biochemistry and Structural Biology<\/p>\n Research interests<\/em>: understanding the causes of the heterogeneous pathology of nonalcoholic steatohepatitis (NASH) with the goal of identifying novel targets to reverse and prevent its progression to hepatocellular carcinoma<\/p>\n <\/p>\n Daohong Zhou, MD<\/strong>, Professor, Department of Biochemistry and Structural Biology;\u00a0Co-director, Drug Discovery and Structural Biology Shared Resource<\/p>\n Research interests<\/em>: developing additional specific antitumor and better senolytic agents using the proteolysis targeting chimera (PROTAC) drug development platform<\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" A listing of new members of the Mays Cancer Center for Fiscal Year 2022. Mays Cancer Center members include those who serve as a principal investigator on a National Institutes of Health research project grant or other equivalent peer-reviewed, cancer-related grant or who are a principal or co-investigator of cancer center clinical trials.<\/p>\n","protected":false},"author":598,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"magazine":[22],"issue-year":[49],"featured-story":[],"class_list":["post-2292","post","type-post","status-publish","format-standard","hentry","category-leadership","magazine-cancer-center","issue-year-49"],"yoast_head":"\n